September 12, 2019
CAR T-cell therapy, a rapidly emerging form of immunotherapy using patients’ own cells to treat certain types of cancers, may be a viable treatment option for another life-threatening condition: heart disease. In a first-of-its-kind study, published in Nature, researchers at Penn Medicine used genetically modified T cells to target and remove activated […]